LEU1_LISMF
ID LEU1_LISMF Reviewed; 512 AA.
AC Q71Y35;
DT 30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT 05-JUL-2004, sequence version 1.
DT 25-MAY-2022, entry version 94.
DE RecName: Full=2-isopropylmalate synthase {ECO:0000255|HAMAP-Rule:MF_01025};
DE EC=2.3.3.13 {ECO:0000255|HAMAP-Rule:MF_01025};
DE AltName: Full=Alpha-IPM synthase {ECO:0000255|HAMAP-Rule:MF_01025};
DE AltName: Full=Alpha-isopropylmalate synthase {ECO:0000255|HAMAP-Rule:MF_01025};
GN Name=leuA {ECO:0000255|HAMAP-Rule:MF_01025};
GN OrderedLocusNames=LMOf2365_2010;
OS Listeria monocytogenes serotype 4b (strain F2365).
OC Bacteria; Firmicutes; Bacilli; Bacillales; Listeriaceae; Listeria.
OX NCBI_TaxID=265669;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=F2365;
RX PubMed=15115801; DOI=10.1093/nar/gkh562;
RA Nelson K.E., Fouts D.E., Mongodin E.F., Ravel J., DeBoy R.T., Kolonay J.F.,
RA Rasko D.A., Angiuoli S.V., Gill S.R., Paulsen I.T., Peterson J.D.,
RA White O., Nelson W.C., Nierman W.C., Beanan M.J., Brinkac L.M.,
RA Daugherty S.C., Dodson R.J., Durkin A.S., Madupu R., Haft D.H.,
RA Selengut J., Van Aken S.E., Khouri H.M., Fedorova N., Forberger H.A.,
RA Tran B., Kathariou S., Wonderling L.D., Uhlich G.A., Bayles D.O.,
RA Luchansky J.B., Fraser C.M.;
RT "Whole genome comparisons of serotype 4b and 1/2a strains of the food-borne
RT pathogen Listeria monocytogenes reveal new insights into the core genome
RT components of this species.";
RL Nucleic Acids Res. 32:2386-2395(2004).
CC -!- FUNCTION: Catalyzes the condensation of the acetyl group of acetyl-CoA
CC with 3-methyl-2-oxobutanoate (2-oxoisovalerate) to form 3-carboxy-3-
CC hydroxy-4-methylpentanoate (2-isopropylmalate). {ECO:0000255|HAMAP-
CC Rule:MF_01025}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=3-methyl-2-oxobutanoate + acetyl-CoA + H2O = (2S)-2-
CC isopropylmalate + CoA + H(+); Xref=Rhea:RHEA:21524, ChEBI:CHEBI:1178,
CC ChEBI:CHEBI:11851, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:57287, ChEBI:CHEBI:57288; EC=2.3.3.13;
CC Evidence={ECO:0000255|HAMAP-Rule:MF_01025};
CC -!- PATHWAY: Amino-acid biosynthesis; L-leucine biosynthesis; L-leucine
CC from 3-methyl-2-oxobutanoate: step 1/4. {ECO:0000255|HAMAP-
CC Rule:MF_01025}.
CC -!- SUBUNIT: Homotetramer. {ECO:0000255|HAMAP-Rule:MF_01025}.
CC -!- SIMILARITY: Belongs to the alpha-IPM synthase/homocitrate synthase
CC family. LeuA type 1 subfamily. {ECO:0000255|HAMAP-Rule:MF_01025}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AE017262; AAT04780.1; -; Genomic_DNA.
DR RefSeq; WP_003725876.1; NC_002973.6.
DR PDB; 3EWB; X-ray; 2.10 A; X=2-283.
DR PDBsum; 3EWB; -.
DR AlphaFoldDB; Q71Y35; -.
DR SMR; Q71Y35; -.
DR KEGG; lmf:LMOf2365_2010; -.
DR HOGENOM; CLU_022158_0_1_9; -.
DR OMA; NTMRMLV; -.
DR UniPathway; UPA00048; UER00070.
DR EvolutionaryTrace; Q71Y35; -.
DR GO; GO:0003852; F:2-isopropylmalate synthase activity; IEA:UniProtKB-UniRule.
DR GO; GO:0009098; P:leucine biosynthetic process; IEA:UniProtKB-UniRule.
DR Gene3D; 3.20.20.70; -; 1.
DR Gene3D; 3.30.160.270; -; 1.
DR HAMAP; MF_01025; LeuA_type1; 1.
DR InterPro; IPR013709; 2-isopropylmalate_synth_dimer.
DR InterPro; IPR002034; AIPM/Hcit_synth_CS.
DR InterPro; IPR013785; Aldolase_TIM.
DR InterPro; IPR036230; LeuA_allosteric_dom_sf.
DR InterPro; IPR005671; LeuA_bact_synth.
DR InterPro; IPR000891; PYR_CT.
DR Pfam; PF00682; HMGL-like; 1.
DR Pfam; PF08502; LeuA_dimer; 1.
DR SMART; SM00917; LeuA_dimer; 1.
DR SUPFAM; SSF110921; SSF110921; 1.
DR TIGRFAMs; TIGR00973; leuA_bact; 1.
DR PROSITE; PS00815; AIPM_HOMOCIT_SYNTH_1; 1.
DR PROSITE; PS00816; AIPM_HOMOCIT_SYNTH_2; 1.
DR PROSITE; PS50991; PYR_CT; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Amino-acid biosynthesis;
KW Branched-chain amino acid biosynthesis; Leucine biosynthesis; Transferase.
FT CHAIN 1..512
FT /note="2-isopropylmalate synthase"
FT /id="PRO_0000140360"
FT DOMAIN 4..266
FT /note="Pyruvate carboxyltransferase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01151"
FT STRAND 2..8
FT /evidence="ECO:0007829|PDB:3EWB"
FT TURN 10..12
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 24..37
FT /evidence="ECO:0007829|PDB:3EWB"
FT STRAND 40..45
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 47..49
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 51..63
FT /evidence="ECO:0007829|PDB:3EWB"
FT STRAND 66..76
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 77..87
FT /evidence="ECO:0007829|PDB:3EWB"
FT STRAND 91..100
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 103..108
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 114..129
FT /evidence="ECO:0007829|PDB:3EWB"
FT STRAND 135..140
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 142..144
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 147..159
FT /evidence="ECO:0007829|PDB:3EWB"
FT STRAND 164..168
FT /evidence="ECO:0007829|PDB:3EWB"
FT STRAND 170..172
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 176..189
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 193..195
FT /evidence="ECO:0007829|PDB:3EWB"
FT STRAND 196..201
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 209..218
FT /evidence="ECO:0007829|PDB:3EWB"
FT STRAND 223..227
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 228..230
FT /evidence="ECO:0007829|PDB:3EWB"
FT TURN 233..235
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 240..249
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 251..254
FT /evidence="ECO:0007829|PDB:3EWB"
FT STRAND 256..258
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 262..264
FT /evidence="ECO:0007829|PDB:3EWB"
FT HELIX 265..274
FT /evidence="ECO:0007829|PDB:3EWB"
SQ SEQUENCE 512 AA; 56064 MW; 475D88C6E46318FF CRC64;
MKKIQFFDTT LRDGEQTPGV NFDVKEKIQI ALQLEKLGID VIEAGFPISS PGDFECVKAI
AKAIKHCSVT GLARCVEGDI DRAEEALKDA VSPQIHIFLA TSDVHMEYKL KMSRAEVLAS
IKHHISYARQ KFDVVQFSPE DATRSDRAFL IEAVQTAIDA GATVINIPDT VGYTNPTEFG
QLFQDLRREI KQFDDIIFAS HCHDDLGMAT ANALAAIENG ARRVEGTING IGERAGNTAL
EEVAVALHIR KDFYQAETNI VLNQFKNSSD LISRLSGMPV PRNKAVIGGN AYAHESGIHQ
DGVLKNPDTY EIITPALVGV DKNSLPLGKL SGKHAFNTRM EEMGYTLTEQ EQKDAFKRFK
QLADAKKEVT EEDLHALILG QSSESADDFE LKHLQVQYVT GGVQGAIVRI EERDGALVED
AATGSGSIEA IYNTINRLMK QDIELTDYRI QAITAGQDAQ AEVHVVIKND KGAVFHGIGI
DFDVLTASAK AYLQASGKSK TASKQADFEE VK